Want to see DH full AI Analyst Report?
DH Stock Chart & Stats
$0.75
>-$0.01(-1.38%)
At close: 4:00 PM EDT
$0.75
>-$0.01(-1.38%)
Day’s Range― - ―
52-Week Range$0.61 - $3.04
Previous Close$0.69
Volume106.08K
Average Volume (3M)649.78K
Market Cap
$159.32M
Enterprise Value$114.59M
Total Cash (Recent Filing)$183.59M
Total Debt (Recent Filing)$167.06M
Price to Earnings (P/E)―
Beta1.51
Next Earnings
Nov 05, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.60
Shares Outstanding106,744,710
10 Day Avg. Volume217,679
30 Day Avg. Volume649,782
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)1.09
Price to Sales (P/S)1.27
P/FCF Ratio8.26
Enterprise Value/Market Cap0.72
Enterprise Value/Revenue0.49
Enterprise Value/Gross Profit0.69
Enterprise Value/Ebitda-0.67
Forecast
1Y Price Target
$1.70Price Target Upside126.67% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)0.2
Revenue Forecast (FY)$221.23M
Bulls Say, Bears Say
Bulls Say
Recurring Subscription Business ModelRecurring subscriptions and embedded healthcare datasets can create durable customer relationships and predictable revenue when products remain central to targeting, planning, and market analysis workflows. This model also provides opportunities for renewals, seat expansion, and add-on data modules over time.
Positive Cash GenerationPositive operating and free cash flow despite reported net losses indicates that the business is currently funding itself internally. This supports continued product investment, debt management, and operational resilience, although the recent moderation in cash conversion warrants monitoring over the next several quarters.
Product Integration And AI DevelopmentFaster integrations and embedded product workflows can improve customer adoption, time to value, renewals, and expansion. The Turbo AI initiative and broader AI embedding add potential differentiation and future product leverage, while current development spending remains directed toward platform capabilities.
Bears Say
Sustained Revenue ContractionDeclining revenue across the current outlook signals that the company is still working through demand and execution pressure rather than compounding growth. Continued contraction could reduce operating leverage, constrain investment capacity, and make a durable return to expansion dependent on successful customer recovery.
Lower Forward Revenue VisibilityLower RPO, deferred revenue, and shorter contract durations reduce the amount of future revenue already committed. That makes forecasting less certain and increases the need to repeatedly win renewals and new business, leaving results more exposed to customer budgeting and sales execution.
Persistent Net LossesPersistent net losses show that strong gross margins have not yet translated into sustainable bottom-line profitability. Ongoing operating and non-operating costs can limit retained capital and weaken returns on equity, while any continued revenue slowdown could make the path to durable earnings more difficult.
Definitive Healthcare Corp News
DH FAQ
What was Definitive Healthcare Corp’s price range in the past 12 months?
Definitive Healthcare Corp lowest stock price was $0.61 and its highest was $3.04 in the past 12 months.
What is Definitive Healthcare Corp’s market cap?
Definitive Healthcare Corp’s market cap is $159.32M.
When is Definitive Healthcare Corp’s upcoming earnings report date?
Definitive Healthcare Corp’s upcoming earnings report date is Nov 05, 2026 which is in 15 days.
How were Definitive Healthcare Corp’s earnings last quarter?
Definitive Healthcare Corp released its earnings results on Aug 10, 2026. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.043 by $0.007.
Is Definitive Healthcare Corp overvalued?
According to Wall Street analysts Definitive Healthcare Corp’s price is currently Undervalued.
Does Definitive Healthcare Corp pay dividends?
Definitive Healthcare Corp does not currently pay dividends.
What is Definitive Healthcare Corp’s EPS estimate?
Definitive Healthcare Corp’s EPS estimate is 0.04.
How many shares outstanding does Definitive Healthcare Corp have?
Definitive Healthcare Corp has 106,744,710 shares outstanding.
What happened to Definitive Healthcare Corp’s price movement after its last earnings report?
Definitive Healthcare Corp reported an EPS of $0.05 in its last earnings report, beating expectations of $0.043. Following the earnings report the stock price went down -7.88%.
Which hedge fund is a major shareholder of Definitive Healthcare Corp?
Currently, no hedge funds are holding shares in DH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Definitive Healthcare Corp Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-62.82%
12-Months-Change
Fundamentals
Return on Equity
-78.52%
Trailing 12-Months
Asset Growth
-35.49%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Definitive Healthcare Corp
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
DH Company Deck
DH Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call conveyed a balanced message: clear near‑term top‑line pressures (Q2 revenue down 9% YoY, RPO and deferred revenue down double digits, professional services softness, and continued life sciences drag) alongside strong profitability, disciplined cost management, robust free cash flow (~$50M TTM), operational progress (integrations, win‑backs, digital activation growth), and product/AI momentum (Turbo pilot and AI embedding). Management tightened full‑year revenue guidance while raising profit/margin guidance and emphasized that improvements in net dollar retention and customer win‑backs underpin confidence in a return to growth over time.View all DH earnings summariesDH Stock 12 Month Forecast
Average Price Target
$1.70
▲(126.67% Upside)
Technical Analysis
Ownership Overview
11.13% Insiders
3.81% Mutual Funds
0.36% Other Institutional Investors
81.63% Public Companies and
Individual Investors